These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37236970)

  • 21. Tau (297-391) forms filaments that structurally mimic the core of paired helical filaments in Alzheimer's disease brain.
    Al-Hilaly YK; Foster BE; Biasetti L; Lutter L; Pollack SJ; Rickard JE; Storey JMD; Harrington CR; Xue WF; Wischik CM; Serpell LC
    FEBS Lett; 2020 Mar; 594(5):944-950. PubMed ID: 31721178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural principles of tau and the paired helical filaments of Alzheimer's disease.
    Mandelkow E; von Bergen M; Biernat J; Mandelkow EM
    Brain Pathol; 2007 Jan; 17(1):83-90. PubMed ID: 17493042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid-state NMR of paired helical filaments formed by the core tau fragment tau(297-391).
    Al-Hilaly YK; Hurt C; Rickard JE; Harrington CR; Storey JMD; Wischik CM; Serpell LC; Siemer AB
    Front Neurosci; 2022; 16():988074. PubMed ID: 36570831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryo-EM structure of Alzheimer's disease tau filaments with PET ligand MK-6240.
    Kunach P; Vaquer-Alicea J; Smith MS; Hopewell R; Monistrol J; Moquin L; Therriault J; Tissot C; Rahmouni N; Massarweh G; Soucy JP; Guiot MC; Shoichet BK; Rosa-Neto P; Diamond MI; Shahmoradian SH
    bioRxiv; 2023 Sep; ():. PubMed ID: 37790438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of the nonhelical filament of the Alzheimer's disease tau core.
    Duan P; Dregni AJ; Mammeri NE; Hong M
    Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310067120. PubMed ID: 37878719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of Tau filaments in Prion protein amyloidoses.
    Hallinan GI; Hoq MR; Ghosh M; Vago FS; Fernandez A; Garringer HJ; Vidal R; Jiang W; Ghetti B
    Acta Neuropathol; 2021 Aug; 142(2):227-241. PubMed ID: 34128081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disease-specific tau filaments assemble via polymorphic intermediates.
    Lövestam S; Li D; Wagstaff JL; Kotecha A; Kimanius D; McLaughlin SH; Murzin AG; Freund SMV; Goedert M; Scheres SHW
    Nature; 2024 Jan; 625(7993):119-125. PubMed ID: 38030728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cryo-EM Structures Reveal Tau Filaments from Down Syndrome Adopt Alzheimer's Disease Fold.
    Ghosh U; Tse E; Yang H; Shi M; Carlo CD; Wang F; Merz GE; Prusiner SB; Southworth DR; Condello C
    bioRxiv; 2024 May; ():. PubMed ID: 38617229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of the binding of thioflavin S to tau paired helical filaments.
    Santa-María I; Pérez M; Hernández F; Avila J; Moreno FJ
    J Alzheimers Dis; 2006 Aug; 9(3):279-85. PubMed ID: 16914838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shapeshifting tau: from intrinsically disordered to paired-helical filaments.
    Mengham K; Al-Hilaly Y; Oakley S; Kasbi K; Maina MB; Serpell LC
    Essays Biochem; 2022 Dec; 66(7):1001-1011. PubMed ID: 36373666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryo-EM structures of tau filaments.
    Scheres SH; Zhang W; Falcon B; Goedert M
    Curr Opin Struct Biol; 2020 Oct; 64():17-25. PubMed ID: 32603876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.
    Jangampalli Adi P; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166162. PubMed ID: 33940164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies.
    Gabellieri E; Capotosti F; Molette J; Sreenivasachary N; Mueller A; Berndt M; Schieferstein H; Juergens T; Varisco Y; Oden F; Schmitt-Willich H; Hickman D; Dinkelborg L; Stephens A; Pfeifer A; Kroth H
    Eur J Med Chem; 2020 Oct; 204():112615. PubMed ID: 32771872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligand polarizability contributes to tau fibril binding affinity.
    Jensen JR; Cisek K; Honson NS; Kuret J
    Bioorg Med Chem; 2011 Sep; 19(17):5147-54. PubMed ID: 21803586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro.
    Seidler PM; Murray KA; Boyer DR; Ge P; Sawaya MR; Hu CJ; Cheng X; Abskharon R; Pan H; DeTure MA; Williams CK; Dickson DW; Vinters HV; Eisenberg DS
    Nat Commun; 2022 Sep; 13(1):5451. PubMed ID: 36114178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.
    Navarrete LP; Pérez P; Morales I; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):678-85. PubMed ID: 21605038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.